dihydroxyphenylalanine has been researched along with Phobic Disorders in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caparros-Lefebvre, D | 1 |
| Cabaret, M | 1 |
| Godefroy, O | 1 |
| Steinling, M | 1 |
| Rémy, P | 1 |
| Samson, Y | 1 |
| Petit, H | 1 |
| Cole, JO | 1 |
2 other studies available for dihydroxyphenylalanine and Phobic Disorders
| Article | Year |
|---|---|
PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism.
Topics: Aged; Antiparkinson Agents; Brain; Dihydroxyphenylalanine; Encephalitis, Arbovirus; Female; Fluorine | 1998 |
The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Topics: Antidepressive Agents; Anxiety Disorders; Attitude of Health Personnel; Behavior Therapy; Brain; Con | 1972 |